William Blair & Company

William Blair & Company’s Mead Johnson Nutrition Company MJN Stock Holding History

William Blair & Company’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-800	Closed	-$56K	–	1539
2016 Q4	$56K	Buy	+800	New	+$59.6K	﹤0.01%	1250

Other funds holding MJN

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return

Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return

Envestnet Asset Management

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

William Blair & Company's MJN Position: Q2 2017 in Review

William Blair & Company sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 151,493 shares — an estimated $13.4M sold.

William Blair & Company first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $316M in Q4 2013. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

William Blair & Company reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
William Blair & Company sold 151,493 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $13.4M.
William Blair & Company first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
William Blair & Company's Mead Johnson Nutrition Company position peaked at $316M in Q4 2013.
7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on William Blair & Company's 13F filing for Q2 2017, filed 4 Aug 2017.